Routine hematological profile in tuberculosis patients undergoing treatment at Bakunase Community Health Center, Kupang City
DOI:
https://doi.org/10.35335/midwifery.v13i6.2224Keywords:
Erythrocyte, Hematological Profile, Hemoglobin, Hematocrit, Indeks Erythrocite, OAT, PlateletAbstract
Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis). Anti-tuberculosis drugs are effective in killing Mycobacterium tuberculosis but may also have side effects on various organs, particularly the hematological system. Monitoring through laboratory examinations, particularly hematological tests, can help prevent complications of other diseases. This descriptive study aimed to determine the hematological profile of tuberculosis patients undergoing treatment at the Bakunase Public Health Center in Kupang City. The population in this study comprised TB patients receiving anti-tuberculosis therapy at the Bakunase Public Health Center in Kupang City, with a total sample of 30 patients. The sampling technique used was purposive sampling. The results showed that TB patients at Bakunase Public Health Center were predominantly male (56.7%), in the productive age group of 19–59 years (83.3%), and mainly in the intensive phase of treatment (0–2 months) (60%). In the productive age group, most hematological parameters were within normal limits, particularly erythrocytes, platelets, hemoglobin, and MCHC. Meanwhile, in the non-productive age group, fewer patients had normal hematological values. Based on treatment duration, patients in both the intensive and continuation phases generally had hematological values within normal limits, although percentages varied.
Downloads
References
Arzaq Nurhadi Fadhilah, R. J. W. (2024). The relationship between the length of treatment for pulmonary tuberculosis patients in the intensive phase and hemoglobin levels. Journal of Indonesian Medical Laboratory and Science, 5(2), 140–149. https://doi.org/10.53699/joimedlabs.v5i2.228
Badan Pusat Statistik Provinsi Nusa Tenggara Timur. (2024). Number of Disease Cases by Regency/City and Type of Disease (People). Ntt.Bps.Go.Id. https://ntt.bps.go.id/indicator/30/1485/1/jumlah-kasus-penyakit-menurut- kabupat en-kota-dan-jenis-penyakit.html
Birhane Reta, Abdurehman Mohammed. Girum Tesfaye, Wondimagegn Adissu, T. S. (2023). Impact of anti-tuberculosis treatment on hematological parameters in newly diagnosed tuberculosis patients at Jimma town: a longitudinal prospective study. Annals Of Medicine & Surgery, 85(8), 3887–3893.
Ervina Julien Sitanggang, J. R. S. (2023). Routine Hematology Profile of Pulmonary TB Patients Before and After Treatment with Antituberculosis Drugs. NJM, 9(1), 65–69.
Eyuel Kassa, Bamlaku Enawgaw, Aschalew Gelaw, B. G. (2016). Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending the University of Gondar Hospital, Northwest Ethiopia. BMC Hematology, 16(1), 1–11. https://doi.org/10.1186/s12878-015-0037-1
Fauziah Hanif, N. C. (2019). The Potential of Garlic (Allium sativum) as an Alternative Anti-Tuberculosis Agent. Majority, 8(1), 220–225.
Firdayanti, S.; N. (2024). Hematological Profile of Anemia Markers In Tuberculosis Patients With Treatment At Puuwatu Health Center, Kendari City. Journal of Nursing and Health, 9(2), 203–210.
Frenky Aipassa, Agnesia Filsa Waas, R. N. (2024). Description of Hemoglobin Levels in Tuberculosis Patients Undergoing Anti-Tuberculosis Drug Therapy at the Maluku Province Community Lung Health Center. Jurnal Kesehatan Tambusai, 5(4), 11254–11258.
Hutauruk, D. S. (2021). Description of Hematocrit Values of Tuberculosis Patients Receiving Anti-Tuberculosis Drug (OAT) Treatment at the Raya Pematang Siantar Community Health Center. Klinikal Sains: Jurnal Analis Kesehatan, 9(1), 36–46. https://doi.org/doi.org/10.36341/klinikal_sains.v9i1.1754
I Gusti Agung Ayu Satwikha Dewi, Ida AYu Manik Partha Sutema, Ni Putu Widiantari, N. K. S. M. D. (2025). Hematology Profile of Tuberculosis Patients Before and After OAT Treatment at Denpasar City Community Health Center. Klinikal Sains: Jurnal Analis Kesehatan, 13(1), 189–204.
Imelda Pongsimpin, Yanti Sunaidi, N. T. (2024). Comparison of Erythrocyte Indices in Tuberculosis Patients Undergoing Initial and Advanced Phase Treatment as a Monitoring of Anemia Risk. Jurnal Analis Kesehatan Kendari, 7(1), 22–29.
Irgie Catur Ryansyah, Sonia Martilova, Evi Susanti Sinaga, K. P. (2023). Factors Influencing Treatment Compliance in TB Patients. CoMPHI Journal, 3(3), 178–183.
Kalma, R., A. R. B. (2019). Trombosit Dan Kadar Hemoglobin Pada Pasien Tuberkulosis Konsumsi Obat Anti Tuberkulosis (OAT). Jurnal Media Analis Kesehatan, 10(2), 143–149. https://doi.org/doi.org/10.32382/mak.v10i2.1302
Mardiyansyah Bahar, Rica Denis, Inayah Hayati, R. Y. (2025). Erythrocyte Sedimentation Rate (ESR) and Hematocrit Profile in Tuberculosis Patients in the Padang Serai Community Health Center Area, Bengkulu City. Jurnal Kajian Ilmiah Kesehatan Dan Teknologi, 7(1), 82–86.
Muhammad Ilyas Yusuf, Firdayanti, S. (2021). Description of Platelet Levels in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Drug Therapy at the Kendari City Regional General Hospital. Jurnal Analis Kesehatan Kendari, III(2), 104–110.
Mukhammad Azmi, Y. Y. (2024). The Correlation Between The Erythrocyte Index And The Extent Of Tuberculosis Lesions In Thorax Radiography. Journal Of Community Health and Preventive Medicine, 4(2), 47–53. https://doi.org/10.21776/ub.jochapm.2024.004.02.4
Mursalim Achmad, Syahida Djasang, N. (2022). Hemoglobin Levels in Pulmonary Tuberculosis Patients Taking Anti-Tuberculosis Drugs. Jurnal Media Analis Kesehatan, 12(1), 64–70.
Nur Fadilah, Maulida Julia Saputri, D. I. Y. (2024). Description of Erythrocyte Indices in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment at the Wonorejo Community Health Center, Samarinda City. Borneo Journal of Medical Laboratory Technology, 7(1), 575–583. https://doi.org/10.33084/bjmlt.v7i1.7562
Permana, A. (2020). Description of Hemoglobin (Hb) and Leukocyte Levels in Pulmonary TB Patients with the Length of OAT (Anti-Tuberculosis Drug) Therapy at the Jakarta Islamic Hospital Cempaka Cempaka. Anakes: Jurnal Ilmiah Analis Kesehatan, 6(2), 136–143. https://doi.org/10.37012/anakes.v6i2.364
Regina Rengsi Putri Wahyuni. (2025). Analysis of Routine Hematology Profile of Pulmonary Tuberculosis Patients Taking Anti-Tuberculosis Drugs. Jurnal Penelitian Multidisiplin Terpadu, 9(7), 448–453.
Roosleyn, I. P. T. (2016). Strategies for Preventing Anemia in Pregnancy. Jurnal Ilmiah Widya, 3(3), 1–9.
Satrio Wahyu Sadewo, Abdul Salam, A. R. (2016). Anemia Status in Pulmonary Tuberculosis Patients in the Lung Disease Treatment Unit of West Kalimantan Province in 2010-2012. Jurnal Cerebellum, 2(3), 590–600.
Shyam S Balepur, D. S. (2016). Hematologic Complications of Tuberculosis. American Society for Microbiology Journal, 4(6). https://doi.org/10.1128/microbiolspec.tnmi7-0004-2016
Stephen, H. M. Frank Palandeng, O. W. (2023). Holistic approach to pulmonary tuberculosis: a case study. Jurnal Kedokteran Komunitas Dan Tropik, 11(1), 449–456.
Tanjung, A. (2024). Analysis of Hematological Examination Results in Pulmonary Tuberculosis (TB) Patients Undergoing Intensive Phase Anti-Tuberculosis Drug Therapy. Journal of Health Science, 17(03), 327–334. https://doi.org/10.33086/jhs.v17.i03.5792
Witi Karwiti, Wuni Sri Lestari, Nasrazuhdy, S. R. (2021). Differences in Hematological Profiles in Pulmonary Tuberculosis Patients Undergoing Treatment. Jambura Journal Of Health Sciences and Research, 3(1), 126–132.
Yuli Kristianingsih, Aryo Prakoso, C. D. P. (2024). Description of Erythrocyte Index in Pulmonary Tuberculosis Patients at Mary Cileungsi General Hospital, Bogor. Jurnal Ilmiah Analis Kesehatan, 10(2), 188–196.
